Literature DB >> 11221954

Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs.

N Takiguchi1, N Saito, M Nunomura, K Kouda, K Oda, N Furuyama, N Nakajima.   

Abstract

PURPOSE: Hyperbaric oxygen (HBO) has been shown to increase tumor radiosensitivity. Several reports indicate that it also increases sensitivity to alkylating agents, but other reports suggest that it may speed angiogenesis and tumor growth. To throw light on these questions, we investigated the effects of HBO and 5-fluorouracil (5-FU), individually and in combination, on Sarcoma 180 implants in mice.
METHODS: We administered 5-FU at a dose of 0.75 mg/mouse six times per week and HBO at 2 atm absolute pressure for 90 min six times per week, both 17 times in total. In combination treatment, HBO was administered immediately after 5-FU injection.
RESULTS: Over the treatment period, tumor diameter increased 277.8% in the untreated control group, 244.1% in the group receiving HBO monotherapy, 182.7% in the group receiving 5-FU monotherapy, and 138.5% in the group receiving combination therapy. Concomitant HBO increased accumulation of 5-FU in the tumors, liver, and kidneys, but not in the brain, of recipient animals.
CONCLUSIONS: Based on the above results, we conclude that concomitant HBO enhances the effects of 5-FU.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11221954     DOI: 10.1007/s002800000190

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  10 in total

1.  Boosting Nanomedicine Efficacy with Hyperbaric Oxygen Therapy.

Authors:  Xiaoxian Wang; Si Li; Xin Liu; Xian Wu; Ningbing Ye; Xiangliang Yang; Zifu Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Hyperbaric oxygen therapy for malignancy: a review.

Authors:  Jurstine Daruwalla; Chris Christophi
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

3.  In vivo growth-inhibition of Sarcoma 180 by an alpha-(1-->4)-glucan-beta-(1-->6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill.

Authors:  Maria Leônia Costa Gonzaga; Daniel Pereira Bezerra; Ana Paula Negreiros Nunes Alves; Nylane Maria Nunes de Alencar; Rodney de Oliveira Mesquita; Michael Will Lima; Sandra de Aguiar Soares; Cláudia Pessoa; Manoel Odorico de Moraes; Letícia Veras Costa-Lotufo
Journal:  J Nat Med       Date:  2008-08-23       Impact factor: 2.343

4.  Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide.

Authors:  Stella Sun; Derek Lee; Nikki P Lee; Jenny K S Pu; Stanley T S Wong; W M Lui; C F Fung; Gilberto K K Leung
Journal:  J Neurooncol       Date:  2012-07-05       Impact factor: 4.130

5.  The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.

Authors:  Angela M Poff; Csilla Ari; Thomas N Seyfried; Dominic P D'Agostino
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

Review 6.  Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours.

Authors:  Katarzyna Stępień; Robert P Ostrowski; Ewa Matyja
Journal:  Med Oncol       Date:  2016-08-02       Impact factor: 3.064

7.  Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice.

Authors:  Zhaohui Lu; Jiawei Ma; Bing Liu; Chungang Dai; Tao Xie; Xiaoyu Ma; Ming Li; Jun Dong; Qing Lan; Qiang Huang
Journal:  Cancer Med       Date:  2016-10-13       Impact factor: 4.452

8.  Combination of carboplatin and intermittent normobaric hyperoxia synergistically suppresses benzo[a]pyrene-induced lung cancer.

Authors:  Hea Yon Lee; In Kyoung Kim; Hye In Lee; Hwa Young Lee; Hye Seon Kang; Chang Dong Yeo; Hyun Hui Kang; Hwa Sik Moon; Sang Haak Lee
Journal:  Korean J Intern Med       Date:  2017-12-15       Impact factor: 2.884

9.  Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells.

Authors:  Xian Wu; Yanhong Zhu; Wei Huang; Jingqiu Li; Bixiang Zhang; Zifu Li; Xiangliang Yang
Journal:  Adv Sci (Weinh)       Date:  2018-06-25       Impact factor: 16.806

10.  Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma.

Authors:  Ingrid Moen; Karl J Tronstad; Odd Kolmannskog; Gerd S Salvesen; Rolf K Reed; Linda E B Stuhr
Journal:  BMC Cancer       Date:  2009-12-17       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.